The AMD Center

Filter Your Results




A Long-Term Treatment Option for AMD?

Treatment of wet age-related macular degeneration (AMD) with anti-VEGF agents currently requires a regimen of frequent…

An interview with Carl D. Regillo, MD

Is Macular Degeneration Slowly Going Away?

Conventional wisdom says that, as the population ages, degenerative diseases will increase in prevalence, meaning a …

Brian C. Joondeph, MD, MPS

Involving Patients in the Care of Their AMD

On a recent Monday in clinic, a 67-year-old patient with severe hypertensive retinopathy pulled out his smartphone a…

Nancy M. Holekamp, MD

In Pursuit of an Earlier Diagnosis

Anti-VEGF monotherapy as a management strategy to treat patients with wet age-related macular degeneration (AMD) has…

Allen C. Ho, MD

Spread the Word

In the 30 years that I have been a practicing comprehensive ophthalmologist I have noticed that, when patients have …

Alan Mendelsohn, MD

Pharmacogenomics and Age-Related Macular Degeneration

Pharmacogenomics is the study of the interaction between drugs and the human genome, in an effort to use a rational …

Demetrios G. Vavvas, MD, PhD

Retina News

Ablate-and-Replace Gene Therapy Was Successful in Mouse Model of RP An approach to gene therapy in which a gene editi…


Aflibercept Improved DR Severity Score at 6 Months in Patients with NPDR In a phase 3 clinical trial, 58% of patients…


This Month's Supplements


Contact Info

Bryn Mawr Communications LLC
1008 Upper Gulph Road, Suite 200
Wayne, PA 19087

Phone: 484-581-1800
Fax: 484-581-1818

Scott Krzywonos

Janet Burk

About Retina Today

Retina Today is a publication that delivers the latest research and clinical developments from areas such as medical retina, retinal surgery, vitreous, diabetes, retinal imaging, posterior segment oncology and ocular trauma. Each issue provides insight from well-respected specialists on cutting-edge therapies and surgical techniques that are currently in use and on the horizon.